Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study

American Journal of Gastroenterology

Volumn 98, Issue 9, 2003, Pages 1931-1939

  Conio, Massimo ^a   Blanchi, Sabrina ^b   Lapertosa, Gabriella ^b   Ferraris, Roberto ^b   Sablich, Renato ^b   Marchi, Santino ^b   D'Onofrio, Vittorio ^b   Lacchin, Teresa ^b   Iaquinto, Gaetano ^b   Missale, Guido ^b   Ravelli, Paolo ^b   Cestari, Renzo ^b   Benedetti, Giorgio ^b   Macrì, Giuseppe ^b   Fiocca, Roberto ^b   Munizzi, Francesco ^b   Filiberti, Rosangela ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; TIME FACTORS;

EID: 0141845135     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07666.x     Document Type: Article

References (62)

1. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-55.
3. Cameron AJ. Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
4. Falk JW. Barrett's esophagus. Gastroenterology 2002;122:1569-91.
5. Spechler SJ, Robbins AH, Bloomfield Rubins H, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984;87:927-33.
6. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
7. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years (see comments). Am J Gastroenterol 1997;92:212-5.
8. Iftikhar SY, James PD, Steele RJ, et al. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
9. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus. Am J Gastroenterol 1999;94:2037-42.
10. Sampliner RE, and the Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
11. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE). Barrett's esophagus: Epidemiological and clinical results of a multicentric survey. Int J Cancer 1991;48:364-8.
12. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence and the extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
13. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
14. Cameron AJ, Souto EO, Smyrk TC. Small adenocarcinomas of the esophagogastric junction: Association with intestinal metaplasia and dysplasia. Am J Gastroenterol 2002;97:1375-80.
15. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: A population-based study. Gastroenterology 2002;122:633-40.
16. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
17. Conio M, Cameron AJ, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001;48:304-9.
18. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999;94:2043-53.
19. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-8.
20. Dent J, Bremner CG, Collen MJ, et al. Working party report to the World Congress of Gastroenterology, Sydney, 1990: Barrett's esophagus. J Gastroenterol Hepatol 1991;6:1-22.
21. Filipe MI, Lake BD. Histochemistry in pathology. Edinburgh: Churchill Livingstone, 1985:675-753.
22. Jass JR. Mucin histochemistry of the columnar epithelium of the oesophagus: A retrospective study. J Clin Pathol 1981;34:866-70.
23. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: A histochemical study. Histopathology 1979;3:191-9.
24. Lapertosa G, Baracchini P, Fulcheri E, and GOSPE (Gruppo Operativo per lo Studio delle Precancerosi Esofagee), Mucin histochemistry in the interpretation of Barrett's esophagus: Results of a multicentric study. Am J Clin Pathol 1992;98:61-6.
25. Schmidt HG, Riddell RH, Walther B, et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 1985;110:145-52.
26. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical application, Hum Pathol 1983;14:931-48.
27. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
28. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995;27:19-26.
29. Bani-Hani K, Sue-Ling H, Johnston D, et al. Barrett's esophagus: Results from a 13-year surveillance programme. Eur J Gastroenterol Hepatol 2000;12:649-54.
30. Savary M, Ollyo JB, Monnier P. Frequency and importance of endobrachyesophagus in reflux disease. In: Siewert JR, Holscher AH, eds. Diseases of the esophagus. New York: Springer-Verlag, 1984:529-36.
31. Van der Burgh A, Dees J, Hop WCJ, et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's esophagus. Gut 1996;39:5-8.
32. Csendes A, Braghetto I, Burdiles P, et al. Long term results of classic anti-reflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 1998;123:645-57.
33. Van der Veen AH, Dees J, Blankensteijn JD, et al. Adenocarcinoma in Barrett's esophagus: An overrated risk. Gut 1989;30:14-8.
34. Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: A prospective controlled investigation. Am J Med 2001;111:33-7.
35. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002;346:836-42.
36. Jankoswki JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West. Gastroenterology 2002;122:588-9.
37. Shaheen NJ, Provenzale D, Sandler R. Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: A review of the evidence. Am J Gastroenterol 2002;97:1319-27.
38. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
39. Wright TA, Gray MR, Morris AI, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-9.
40. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Int Med 1999;130:883-90.
41. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol and socioeconomic status and adenocarcinoma of the esophagus and gastric cardia. J Natl Cancer Inst 1997;89:1277-84.
42. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length for neoplastic progression in patients with Barrett's esophagus. Ann Int Med 2000;132:612-20.
43. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic changes in Barrett's esophagus. Br J Surg 1988;75:760-3.
44. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1248-56.
45. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991;32:1441-6.
46. Van Sandick JW, Van Lanschot JJB, Kuiken BW, et al. Impact of endoscopic biopsy surveillance on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
47. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999;94:3413-9.
48. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia and early adenocarcinoma: A pathologic study. Am J Gastroenterol 1997;92:586-91.
49. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
50. Skacel M, Petras RE, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383-7.
51. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
52. Alikhan M, Rex D, Khan A, et al. Variable pathologic interpretation by general pathologists in community practice. Gastrointest Endosc 1999;50:23-6.
53. Vieth M, Stolte M. Barrett's esophagus and neoplasia: Data from the Bayreuth Barrett's archive. Gastroenterology 2002;122:590.
54. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-19.
55. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7.
56. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-7.
57. Macdonald CE. Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett's esophagus: Observational study. BMJ 2000;321:1252-5.
58. Shaheen N. Is there a "Barrett's iceberg"? Gastroenterology 2002;123:636-9.
59. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophageal adenocarcinoma: A systematic review. Gastroenterology 2002;122:26-33.
60. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379-88.
61. Katz D, Rothstein R, Schned A, et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998;93:536-41.
62. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subset. Am J Gastroenterol 2000;95:1669-76.